Peptide Stack Guide

Semax + Selank Stack Explained

A nootropic pairing built on two different individual reputations: focus from one, calm from the other. Here's why the two are combined, what's actually known about each compound separately, and what the evidence base does not cover.

Last reviewed September 29, 2026 7 min read By Dave Belmonte, Founder
Semax Selank Stack Guide
Back to Expert Insights

Quick Stack Summary

 SemaxSelank
Parent structureSynthetic ACTH(4-10) analogSynthetic tuftsin analog
Primary associationFocus, cognition, neuroprotectionReduced anxiety without sedation
Proposed mechanismsBDNF expression, dopaminergic and serotonergic modulationGABAergic signaling, enkephalin-degrading enzyme inhibition, some BDNF influence
Russian clinical historyNasal spray, stroke recovery and cognitive impairmentNasal drops
Combined-arm trialNone identified

Why These Two Are Often Combined

Semax is generally associated with mental focus and cognitive sharpness, while Selank is generally associated with calm and reduced anxiety without the sedation that typically comes with anti-anxiety approaches. The appeal of stacking them is getting both effects at once: clear-headed focus without anxious jitteriness, or calm without brain fog. For a closer look at how the two compare head to head, see Semax vs Selank.

Extrapolation, not a tested combination: this rationale is built from each compound's separate, individually reported effects, not from a demonstrated combined outcome in a controlled trial. No published research has specifically studied Semax and Selank administered together. As with other stacks on this site, the case for pairing them rests on separate compound research, not a dedicated combined-arm study, and that distinction is worth keeping in mind before treating the pairing as more established than it is.

Semax's Role

Semax is a synthetic peptide analog of ACTH(4-10), studied mainly for cognitive enhancement, focus, and neuroprotection. Proposed mechanisms include increased BDNF expression and modulation of dopaminergic and serotonergic systems. It has a documented history of clinical and medical use in Russia, administered as a nasal spray in contexts including stroke recovery and cognitive impairment.

Selank's Role

Selank is a synthetic analog of tuftsin, studied mainly for anxiolytic effects without sedation, along with some immune-modulating research. Proposed mechanisms include effects on GABAergic signaling, inhibition of enkephalin-degrading enzymes, and some influence on BDNF expression. Like Semax, it has a documented Russian clinical and registration history, administered as nasal drops.

Timing and Practical Notes

Because Semax and Selank are both typically administered intranasally in the same dosing windows people already use for each compound on its own, they are often taken together or staggered by a few minutes rather than requiring a separate schedule. Some people report using Semax earlier in the day for focus and reserving Selank for periods when anxiety or stress is more likely to interfere with concentration. This is a matter of individual pattern and preference rather than a protocol validated by research on the combination, and there is no published dosing schedule specific to running them together.

Safety Considerations

Neither Semax nor Selank is FDA-approved. Both are sold in the United States as research chemicals outside their historical Russian registration, which means neither carries the kind of large-scale, peer-reviewed human safety data that an approved medication would have. Combining two compounds means combining whatever individual safety unknowns each one carries, not just their intended effects, and that is true here even though both compounds are generally described as well tolerated individually. For what's actually been shown for each compound in humans, see the evidence reviews for Semax and Selank.

Russia versus Western evidence: both Semax and Selank individually have more clinical and registration history in Russia than peer-reviewed trial data in Western research settings, a gap covered in more depth on each compound's evidence review page linked above. Since no combined study of the two exists at all, that visibility gap applies doubly to this stack. Even less is known about the pairing specifically than about either compound alone in a Western research context.

A Note on Bloodwork

Neither Semax nor Selank has a standard clinical marker tied to its mechanism, so there is no single blood test that shows whether either compound is doing what it is intended to do. A general safety baseline, a comprehensive metabolic panel and a CBC, is a reasonable starting point before running any peptide protocol, not because either compound is known to move those markers, but as ordinary due diligence before starting something new.

For the mechanism comparison behind this stack, see Semax vs Selank. For what's actually been studied in humans versus animals, see the evidence reviews for Semax and Selank. BioStackIQ's Rate My Stack and Build Protocol can help plan timing once a direction is chosen.

Frequently Asked Questions

Disclaimer: This content is for informational purposes only and does not constitute medical advice. Semax and Selank are not currently sold as FDA-approved prescription products. Always consult a qualified healthcare provider before starting any peptide protocol.